Colorectal signet‐ring cell carcinoma: benefit from adjuvant chemotherapy but a poor prognostic factor

Colorectal signet‐ring cell carcinoma (SRCC) has been associated with poor survival compared with mucinous adenocarcinoma (MC) and the more common adenocarcinoma (AC). Efficacy of adjuvant chemotherapy in SRCC has never been assessed. This study analyzes the prognostic impact of SRCC and determines...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	International journal of cancer 2015-01, Vol.136 (2), p.333-339
Hauptverfasser:	Hugen, Niek, Verhoeven, Rob H., Lemmens, Valery E, van Aart, Carola J., Elferink, Marloes A., Radema, Sandra A., Nagtegaal, Iris D., de Wilt, Johannes H.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adenocarcinoma - drug therapy Adenocarcinoma - epidemiology Adenocarcinoma - mortality Adenocarcinoma, Mucinous - drug therapy Adenocarcinoma, Mucinous - epidemiology Adenocarcinoma, Mucinous - mortality adjuvant chemotherapy Aged Antineoplastic Combined Chemotherapy Protocols - therapeutic use Cancer Carcinoma, Signet Ring Cell - drug therapy Carcinoma, Signet Ring Cell - epidemiology Carcinoma, Signet Ring Cell - mortality Chemotherapy Chemotherapy, Adjuvant Colorectal cancer Colorectal Neoplasms - drug therapy Colorectal Neoplasms - epidemiology Colorectal Neoplasms - mortality Combined Modality Therapy epidemiology Female Follow-Up Studies Humans Male Medical prognosis Medical research Middle Aged mucinous carcinoma Neoplasm Staging Netherlands - epidemiology Prognosis signet‐ring cell carcinoma Survival Rate
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!